Annual Working Capital
$85.22 M
-$1.14 M-1.31%
31 December 2023
Summary:
Lyra Therapeutics annual working capital is currently $85.22 million, with the most recent change of -$1.14 million (-1.31%) on 31 December 2023. During the last 3 years, it has risen by +$14.19 million (+19.98%). LYRA annual working capital is now -1.31% below its all-time high of $86.36 million, reached on 31 December 2022.LYRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$39.49 M
-$10.67 M-21.27%
30 September 2024
Summary:
Lyra Therapeutics quarterly working capital is currently $39.49 million, with the most recent change of -$10.67 million (-21.27%) on 30 September 2024. Over the past year, it has dropped by -$46.20 million (-53.91%). LYRA quarterly working capital is now -64.90% below its all-time high of $112.51 million, reached on 30 June 2022.LYRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.3% | -53.9% |
| 3 y3 years | +20.0% | -8.4% |
| 5 y5 years | +271.1% | - |
LYRA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.3% | +187.2% | -64.9% | +73.6% |
| 5 y | 5 years | -1.3% | +1635.4% | -64.9% | +704.1% |
| alltime | all time | -1.3% | +1635.4% | -64.9% | +704.1% |
Lyra Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $39.49 M(-21.3%) |
| June 2024 | - | $50.16 M(-29.1%) |
| Mar 2024 | - | $70.72 M(-17.0%) |
| Dec 2023 | $85.22 M(-1.3%) | $85.22 M(-0.5%) |
| Sept 2023 | - | $85.69 M(-17.7%) |
| June 2023 | - | $104.14 M(+47.4%) |
| Mar 2023 | - | $70.64 M(-18.2%) |
| Dec 2022 | $86.36 M | $86.36 M(-12.4%) |
| Sept 2022 | - | $98.63 M(-12.3%) |
| June 2022 | - | $112.51 M(+394.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $22.75 M(-23.3%) |
| Dec 2021 | $29.67 M(-58.2%) | $29.67 M(-31.2%) |
| Sept 2021 | - | $43.11 M(-32.8%) |
| June 2021 | - | $64.17 M(+1.6%) |
| Mar 2021 | - | $63.18 M(-11.1%) |
| Dec 2020 | $71.03 M(+1346.4%) | $71.03 M(-9.9%) |
| Sept 2020 | - | $78.85 M(-7.6%) |
| June 2020 | - | $85.37 M(+181.0%) |
| Mar 2020 | - | $30.38 M(+518.7%) |
| Dec 2019 | $4.91 M(-78.6%) | $4.91 M |
| Dec 2018 | $22.97 M | - |
FAQ
- What is Lyra Therapeutics annual working capital?
- What is the all time high annual working capital for Lyra Therapeutics?
- What is Lyra Therapeutics annual working capital year-on-year change?
- What is Lyra Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly working capital year-on-year change?
What is Lyra Therapeutics annual working capital?
The current annual working capital of LYRA is $85.22 M
What is the all time high annual working capital for Lyra Therapeutics?
Lyra Therapeutics all-time high annual working capital is $86.36 M
What is Lyra Therapeutics annual working capital year-on-year change?
Over the past year, LYRA annual working capital has changed by -$1.14 M (-1.31%)
What is Lyra Therapeutics quarterly working capital?
The current quarterly working capital of LYRA is $39.49 M
What is the all time high quarterly working capital for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly working capital is $112.51 M
What is Lyra Therapeutics quarterly working capital year-on-year change?
Over the past year, LYRA quarterly working capital has changed by -$46.20 M (-53.91%)